NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. Its principal product offering is based on its Maximum Access Surgery, or MAS platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. 
Type
Public
HQ
San Diego, US
Founded
1997
Size (employees)
2,300 (est)+5%
NuVasive was founded in 1997 and is headquartered in San Diego, US
Report incorrect company information

NuVasive Office Locations

NuVasive has an office in Memphis, Columbia, San Diego, Fairborn and in 9 other locations
San Diego, US (HQ)
7475 Lusk Blvd
Aliso Viejo, US
100 101 Enterprise
Columbia, US
250 10420 Little Patuxent Pkwy
Fairborn, US
1 Herald Square
Memphis, US
101 4670 E Shelby Dr
Kew, AU
620 High St
Show all (13)
Report incorrect company information

NuVasive Financials and Metrics

NuVasive Financials

NuVasive's revenue was reported to be $962.07 m in FY, 2016 which is a 18.6% increase from the previous period.
USD

Revenue (Q3, 2017)

247.4 m

Gross profit (Q3, 2017)

181.8 m

Gross profit margin (Q3, 2017), %

73.5%

Net income (Q3, 2017)

33.2 m

Market capitalization (5-Feb-2018)

2.5 b

Cash (3-Feb-2018)

62.2 m

EV

2.5 b
NuVasive's current market capitalization is $2.5 b.
Annual
USDFY, 2013Y, 2014Y, 2015FY, 2016

Revenue

685.2 m762.4 m811.1 m962.1 m

Revenue growth, %

11%6%19%

Cost of goods sold

180.5 m182.4 m194.5 m240.1 m

Gross profit

504.7 m580.1 m616.6 m722 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

192.4 m202.9 m200.5 m215 b236.2 m239.6 m249.9 m260.6 m247.4 m

Cost of goods sold

45.7 m48.4 m49.2 m54.2 b59.7 m59.2 m61.6 m66.4 m65.6 m

Gross profit

146.7 m154.5 m151.4 m160.8 b176.5 m180.5 m188.3 m194.2 m181.8 m

Gross profit Margin, %

76%76%75%75%75%75%75%75%73%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

102.8 m142.4 m192.3 m153.6 m

Inventories

10.9 m21.6 m8.8 m208.2 m

Current Assets

536 m705.9 m702.8 m575.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

100.6 m110.8 m106.5 m130.7 m88.5 m78.6 m141.3 m270.1 m263.1 m203.8 m134 m130.9 m62.2 m

Accounts Receivable

96.2 m

Inventories

140.7 m147.7 m157.4 m159.7 m163.4 m163.7 m164.9 m200.7 m201.9 m212.8 m223.1 m236.8 m249 m

Current Assets

488 m606.3 m587.1 m629.6 m632.9 m684.3 m698.5 m692.2 m712 m616.9 m563.3 m592.2 m529.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7 m(17.5 m)65.3 m35.4 m

Depreciation and Amortization

63.1 m65.8 m65.9 m42 m

Inventories

(3.6 m)(5.2 m)1.2 m(22.6 m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m24.6 m57.7 m

Depreciation and Amortization

16.1 m32.6 m49 m21.2 m46.3 m73.8 m29.5 m58.7 m88.9 m

Inventories

157.4 m159.7 m(11.4 m)(15.2 m)(19.8 m)(9.4 m)(12 m)(22.4 m)(13.6 m)(29 m)(36.2 m)

Cash From Operating Activities

26 m35.2 m48 m57.4 m100.2 m96 m28 m67.1 m118.9 m
USDY, 2017

EV/CFO

21.2 x

Revenue/Employee

112.5 k

Financial Leverage

2.1 x
Show all financial metrics

NuVasive Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
SafePassage December 12, 2017
Biotronic NeuroNetwork June 06, 2016$98 m
Ellipse Technologies January 05, 2016$410 m
Report incorrect company information